| 摘要 |
In the manufacture of a pharmaceutical preparation for the treatment of obesity, satins (such as rosuvastatin, atorvastatin, simvastatin, fluvastatin, pravastatin or terbinafine), interferon alpha -2b, interleukin (IL)-4 (IL-4), IL-13 or other IL-4 receptor antagonist other than IL-4 and IL-13 or their analogues, are used. - ACTIVITY - Anorectic; Antidiabetic; Hypotensive; Cardiovascular-Gen. - MECHANISM OF ACTION - HMG CoA reductase inhibitor; Interleukin-4 receptor agonist. |
